Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2014

Feb 13, 2014

30071_dirs_2014-02-13_6e2d90fc-462f-4644-b438-1ce0a72a547d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-02-11

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-11 ResMed Common Stock M 5000 $15.520 Acquired 73955.566 Direct
2014-02-11 ResMed Common Stock S 5000 $45.591 Disposed 68955.566 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-11 ResMed Stock Options $15.52 M 5000 Disposed 2015-11-20 ResMed Common Stock (5000) Direct

Footnotes

F1: Represents date options first became exercisable. Options vest 1/4 annually on the anniversary of the grant.